Luteal phase estradiol level: a potential predictive marker for successful pregnancy in in vitro fertilization/intracytoplasmic sperm injection

Fertil Steril. 2009 Apr;91(4):1018-22. doi: 10.1016/j.fertnstert.2008.01.074. Epub 2008 Mar 21.

Abstract

Objective: To analyze the role of luteal E(2), P, and FSH levels in the prediction of clinical pregnancy in stimulated cycles.

Design: Prospective study.

Setting: Institute of Reproductive Medicine, Salt Lake, Kolkata, India.

Patient(s): A total of 268 women aged <40 years undergoing their first IVF-ET/intracytoplasmic sperm injection cycles.

Intervention(s): Estimation of luteal phase serum E(2), P, and FSH levels on days 0, 7, and 14 of ET.

Main outcome measure(s): Comparison of luteal phase hormonal profile in pregnant and nonpregnant women and interpretation by discriminant analysis.

Result(s): A total of 113 pregnancies were achieved (42.16%). Age, basal FSH level, peak E(2) level, number of oocytes retrieved, and number of embryos transferred were comparable between pregnant and nonpregnant women. Day-7 and day-14 luteal E(2) levels were significantly different between the two groups. Progesterone levels were comparable in both groups on days 0 and 14. Levels of FSH showed statistically significant differences between the two groups on days 0, 7, and 14. Classification accuracy for E(2), P, and FSH was 82.1%, 60.8%, and 67.51%, respectively.

Conclusion(s): Luteal E(2) concentration seems to be a promising marker of successful clinical pregnancy.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Biomarkers / analysis
  • Biomarkers / blood
  • Estradiol / analysis
  • Estradiol / blood*
  • Female
  • Fertilization in Vitro*
  • Follicle Stimulating Hormone / blood
  • Humans
  • Infertility / blood
  • Infertility / diagnosis*
  • Infertility / therapy
  • Luteal Phase / blood*
  • Male
  • Predictive Value of Tests
  • Pregnancy
  • Pregnancy Rate
  • Progesterone / blood
  • Prognosis
  • Sensitivity and Specificity
  • Sperm Injections, Intracytoplasmic*
  • Treatment Outcome

Substances

  • Biomarkers
  • Progesterone
  • Estradiol
  • Follicle Stimulating Hormone